These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 38656981)
1. Integrative Salt Selection and Formulation Optimization: Perspectives of Disproportionation and Microenvironmental pH Modulation. Mohan S; Li Y; Chu K; De La Paz L; Sperger D; Shi B; Foti C; Rucker V; Lai C Mol Pharm; 2024 May; 21(5):2590-2605. PubMed ID: 38656981 [TBL] [Abstract][Full Text] [Related]
2. Effect of Excipients on Salt Disproportionation during Dissolution: A Novel Application of In Situ Raman Imaging. Abouselo A; Rance GA; Tres F; Taylor LS; Kwokal A; Renou L; Scurr DJ; Burley JC; Aylott JW Mol Pharm; 2021 Sep; 18(9):3247-3259. PubMed ID: 34399050 [TBL] [Abstract][Full Text] [Related]
3. Modulation of Microenvironmental Acidity: A Strategy to Mitigate Salt Disproportionation in Drug Product Environment. Koranne S; Lalge R; Suryanarayanan R Mol Pharm; 2020 Apr; 17(4):1324-1334. PubMed ID: 32142293 [TBL] [Abstract][Full Text] [Related]
4. Implementing quality by design in pharmaceutical salt selection: a modeling approach to understanding disproportionation. Merritt JM; Viswanath SK; Stephenson GA Pharm Res; 2013 Jan; 30(1):203-17. PubMed ID: 22918819 [TBL] [Abstract][Full Text] [Related]
5. Salt disproportionation: A material science perspective. Thakral NK; Kelly RC Int J Pharm; 2017 Mar; 520(1-2):228-240. PubMed ID: 28163222 [TBL] [Abstract][Full Text] [Related]
6. Crystalline solid dispersion-a strategy to slowdown salt disproportionation in solid state formulations during storage and wet granulation. Nie H; Xu W; Taylor LS; Marsac PJ; Byrn SR Int J Pharm; 2017 Jan; 517(1-2):203-215. PubMed ID: 27979765 [TBL] [Abstract][Full Text] [Related]
7. Stabilization of the maleate salt of a basic drug by adjustment of microenvironmental pH in solid dosage form. Zannou EA; Ji Q; Joshi YM; Serajuddin AT Int J Pharm; 2007 Jun; 337(1-2):210-8. PubMed ID: 17296277 [TBL] [Abstract][Full Text] [Related]
8. Disproportionation of Pharmaceutical Salts: pH Avdeef A Mol Pharm; 2021 Jul; 18(7):2724-2743. PubMed ID: 34142831 [TBL] [Abstract][Full Text] [Related]
9. Salt Disproportionation in the Solid State: Role of Solubility and Counterion Volatility. Thakral NK; Behme RJ; Aburub A; Peterson JA; Woods TA; Diseroad BA; Suryanarayanan R; Stephenson GA Mol Pharm; 2016 Dec; 13(12):4141-4151. PubMed ID: 27766882 [TBL] [Abstract][Full Text] [Related]
10. Effect of Microenvironmental pH Modulation on the Dissolution Rate and Oral Absorption of the Salt of a Weak Acid - Case Study of GDC-0810. Hou HH; Jia W; Liu L; Cheeti S; Li J; Nauka E; Nagapudi K Pharm Res; 2018 Jan; 35(2):37. PubMed ID: 29380076 [TBL] [Abstract][Full Text] [Related]
11. Disproportionation of a crystalline citrate salt of a developmental pharmaceutical compound: characterization of the kinetics using pH monitoring and online Raman spectroscopy plus quantitation of the crystalline free base form in binary physical mixtures using FT-Raman, XRPD and DSC. Skrdla PJ; Zhang D J Pharm Biomed Anal; 2014 Mar; 90():186-91. PubMed ID: 24378612 [TBL] [Abstract][Full Text] [Related]
12. Formulating weakly basic HCl salts: relative ability of common excipients to induce disproportionation and the unique deleterious effects of magnesium stearate. John CT; Xu W; Lupton LK; Harmon PA Pharm Res; 2013 Jun; 30(6):1628-41. PubMed ID: 23512680 [TBL] [Abstract][Full Text] [Related]
13. Analytical approaches to investigate salt disproportionation in tablet matrices by Raman spectroscopy and Raman mapping. Nie H; Liu Z; Marks BC; Taylor LS; Byrn SR; Marsac PJ J Pharm Biomed Anal; 2016 Jan; 118():328-337. PubMed ID: 26590700 [TBL] [Abstract][Full Text] [Related]
14. Evaluating drug delivery with salt formation: Drug disproportionation studied in situ by ATR-FTIR imaging and Raman mapping. Ewing AV; Wray PS; Clarke GS; Kazarian SG J Pharm Biomed Anal; 2015; 111():248-56. PubMed ID: 25910459 [TBL] [Abstract][Full Text] [Related]
15. Salt formation improved the properties of a candidate drug during early formulation development. Sigfridsson K; Ahlqvist M; Lindsjö M; Paulsson S Eur J Pharm Sci; 2018 Jul; 120():162-171. PubMed ID: 29730322 [TBL] [Abstract][Full Text] [Related]
16. Fumaric acid microenvironment tablet formulation and process development for crystalline cenicriviroc mesylate, a BCS IV compound. Menning MM; Dalziel SM Mol Pharm; 2013 Nov; 10(11):4005-15. PubMed ID: 23941629 [TBL] [Abstract][Full Text] [Related]
17. Impact of Metallic Stearates on Disproportionation of Hydrochloride Salts of Weak Bases in Solid-State Formulations. Nie H; Xu W; Ren J; Taylor LS; Marsac PJ; John CT; Byrn SR Mol Pharm; 2016 Oct; 13(10):3541-3552. PubMed ID: 27542728 [TBL] [Abstract][Full Text] [Related]
18. Investigation of Spatial Heterogeneity of Salt Disproportionation in Tablets by Synchrotron X-ray Diffractometry. Koranne S; Govindarajan R; Suryanarayanan R Mol Pharm; 2017 Apr; 14(4):1133-1144. PubMed ID: 28195490 [TBL] [Abstract][Full Text] [Related]
19. Synthon Approach in Crystal Engineering to Modulate Physicochemical Properties in Organic Salts of Chlorpropamide. Menon AM; Sidhartha NN; Shruti I; Suresh A; Meena R; Dikundwar AG; Chopra D Mol Pharm; 2024 Jun; 21(6):2894-2907. PubMed ID: 38688017 [TBL] [Abstract][Full Text] [Related]
20. Microenvironmental pH-modification to improve dissolution behavior and oral absorption for drugs with pH-dependent solubility. Taniguchi C; Kawabata Y; Wada K; Yamada S; Onoue S Expert Opin Drug Deliv; 2014 Apr; 11(4):505-16. PubMed ID: 24472170 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]